Back

HDL particle size and apolipoprotein content, and cardiovascular disease risk in chronic kidney disease: the multi-ethnic study of atherosclerosis

11 April 2019 (15:30 - 16:30)
Organised by:
Congress Presentation Part of: Moderated Posters Session 2 Lipids EAPC Premium Access EuroPrevent 2019

About the speaker

Photo
Doctor Julio Alejandro Lamprea Montealegre

UCSF Medical Centre, San Francisco (United States of America)

9 More presentations in this session

Presentation thumbnail
Dysfunction of key canonical signaling pathways, miR-223 and miR-126 are associated to the development of major cardiovascular complications
Mrs C. Eyileten (Warsaw, PL)
Abstract Slides
Presentation thumbnail
Moderate intense exercise as a new therapeutic strategy to tackle abdominal venous congestion in heart failure
Miss J. Cops (Hasselt, BE)
Abstract Slides
Presentation thumbnail
Derivation and validation of a new scoring system to stratify post-surgical valvular patients during cardiovascular rehabilitation
Doctor F. Maranta (Milan, IT)
Abstract Slides
Presentation thumbnail
Monitoring food and beverage marketing to children via television in Russian Federation, Kazakhstan Republic and Kyrgyz Republic
Doctor Y. Balanova (Moscow, RU)
Abstract Slides
Presentation thumbnail
Cardioprotective effect of MMP-2-inhibitor-NO-donor hybrid during ischemia/reperfusion injury
Assistant Professor I. Bil-Lula (Wroclaw, PL)
Abstract Slides

Access the full session

Session thumbnail
Moderated Posters Session 2

The Event

Event poster

EuroPrevent 2019

11 April 2019 15:30 CET
You may be interested in
thumbnail
Congress Session
Optimising cardiovascular risk prediction and management in patients with renal disease
4 April 2025
thumbnail
Congress Presentation
Association of HDL composition and functionality with markers of subclinical vascular disease in individuals with extremely high HDL
30 August 2025
thumbnail
Congress Presentation
Apolipoprotein B outperforms low density lipoprotein particle number as a marker of cardiovascular risk in the UK biobank
1 September 2025
thumbnail
Congress Presentation
Triglyceride-associated markers and genetic variants of eNOS3 in the stratification of residual cardiorenal risk in patients with arterial hypertension and diabetic nephropathy
24 April 2026

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources